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Protein ubiquitination patterns are an important
component of cellular signaling. The WD-repeat
protein WDR48 (USP1-associated factor UAF-1)
stimulates activity of ubiquitin-specific proteases
USP1, USP12, and USP46. To understand how
WDR48 exerts its effect on the USP scaffold,
we determined structures of the ternary WDR48:
USP46:ubiquitin complex. WDR48 interacts with
the USP46 fingers subdomain via a relatively small,
highly polar surface on the top center of the WDR48
b propeller. In addition, WDR48 has a novel ancil-
lary domain and a C-terminal SUMO-like domain
encircling the USP46-bound ubiquitin. Mutation of
residues involved in the WDR48:USP46 interaction
abrogated both binding and deubiquitinase activity
of the complex. An analogous mutation in USP1
similarly blocked WDR48-dependent activation.
Our data suggest a possible mechanism of deubi-
quitinase stimulation via stabilization and pro-
longed residence time of substrate. The unprece-
dented mode of interaction between the USP
fingers domain and the WD-repeat b propeller
serves as a prototypical example for this family of
deubiquitinases.
INTRODUCTION
Post-translational modification of proteins provides rich patterns
of alterations with widespread functional consequences.
Reversible covalent attachment of ubiquitin occurs via isopep-
tide linkage of the ubiquitin C terminus to substrate protein ly-
sines. Polyubiquitin chains can extend from any of the seven
lysine residues of ubiquitin itself, and diversity is further amplified
by branching and the combinatorial possibilities of these varied
linkages (Komander and Rape, 2012). These modifications are
important in targeting proteins to the proteasome (Hershko
et al., 1982), as well as in an expansive set of non-degradative
roles: regulating DNA repair (Nijman et al., 2005), signaling, tran-
scription (Ko¨hler et al., 2010; Samara et al., 2010), cell-cycle con-
trol (Teixeira and Reed, 2013), mitochondrial integrity (BingolStructure 23, 2043–20et al., 2014), and the generation and recycling of free ubiquitin
(Reyes-Turcu and Wilkinson, 2009).
A large set of 95 known deubiquitinases (DUBs) comprising
five families regulates specific removal of ubiquitin. Among
these, the ubiquitin-specific proteases (USPs) form the largest
group, with 58 members that share a common catalytic domain
of350 amino acids (Komander et al., 2009). Insertions variously
elaborate the core USP scaffold such that the largest members
exceed 1,000 residues in length (Komander et al., 2009; Ye
et al., 2009). The conserved USP architecture features ‘‘thumb’’
and ‘‘palm’’ subdomains that bear the Cys-protease catalytic
triad (Cys, His, Asp), while an extended ‘‘fingers’’ subdomain,
often including a zinc-coordinating motif, helps cradle ubiquitin
and orient its C terminus toward the catalytic active site.
Several free USP structures (e.g. USP14, USP8) show features
incompatible with enzymatic activity, whether due to ubiquitin-
proximal loops (Hu et al., 2005), non-productive catalytic residue
and ‘‘switch loop’’ orientation in USP7 (Faesen et al., 2011a), or
inward motion of the fingers domain (Avvakumov et al., 2006).
Binding of ubiquitin substrate imparts conformational changes
in these examples, notably motions of the fingers domain as
well as USP loops near the ubiquitin site and the catalytic center,
into ubiquitin-accommodating conformations (Hu et al., 2002;
Molland et al., 2014).
Two studies of allosteric USP binding partners have shown
direct contacts with features in close proximity to the USP active
site and the palm and thumb domains. The C-terminal ubiquitin-
like domains (UBL) 4 and 5 of USP7 appear to mediate stimula-
tory effects through intramolecular contact with the USP7
switching loop, an interaction further potentiated through stabi-
lization of USP7 UBL1-3 by guanosine monophosphate synthe-
tase (Faesen et al., 2011a). Structures of the yeast SAGA
DUB module describe intertwined co-factors (Sus1, Sgf75, and
Sgf11) that form an intricate set of scaffolding interactions
packing against the palm and thumb subdomains of the USP
fold Ubp8. These co-factors thereby organize the active site
and provide a measure of global Ubp8 stabilization to balance
its intrinsic flexibility (Ko¨hler et al., 2010; Samara et al., 2010).
Detailed understanding of the mechanism of DUB activation
by partner proteins has remained challenging. In a proteomic
screen, numerousWD-40 repeat proteins, named for a signature
Trp-Asp repeat and typically found as b-propeller scaffolds in
diverse protein complexes, were implicated in interactions with
20 different USPs (Sowa et al., 2009). WDR48 (also known as
USP1-associated factor 1, UAF-1) stimulates the activity of54, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2043
USP1 (Cohn et al., 2007) as well as that of two smaller homologs,
USP12 and USP46 (Cohn et al., 2009). USP1 regulates DNA-
damage response, specifically the Fanconi anemia and transle-
sion DNA synthesis (TLS) pathways, by deubiquitination of
FANCD2 and PCNA substrates to affect their recruitment of
DNA repair complexes to damage sites (Huang et al., 2006;
Murai et al., 2011; Park et al., 2013; Yang et al., 2011). Height-
ened USP1 activity maintains cells in an undifferentiated state
in the context of osteosarcoma, as deubiquitination of ID (‘‘inhib-
itors of DNA binding’’) transcription factors leads to their
increased stability and antagonism of differentiation-promoting
basic helix-loop-helix transcription factors (Williams et al.,
2011). Prominent in DNA repair, USP1 is a potential target for
cancer therapy (Chen et al., 2011; Garcı´a-Santisteban et al.,
2013; Liang et al., 2014; Villamil et al., 2013). USP12 is a compo-
nent of the Akt signaling pathway (Gangula and Maddika, 2013),
with ties to androgen receptor activation (McClurg et al., 2014).
Both USP12 and USP46 deubiquitinate histone H2A and H2B,
affecting Xenopus development (Joo et al., 2011), and, unlike
USP1, these smaller USPs can simultaneously bind WDR20 in
addition to WDR48 (Joo et al., 2011; Kee et al., 2010). USP1,
12, and 46 may also be involved in papillomavirus propagation,
as the viral E1 protein recruits these DUBs to its origin of replica-
tion via interaction with WDR48, and abrogation of their deubi-
quitinase activity significantly reduces viral replication (Lehoux
et al., 2014).
USP1, 12, and 46 are unified by their dependence on WDR48,
which stimulates their activities by approximately 10- to 30-fold.
This effectmay bemediatedmore by altering turnover (kcat) rather
than substrate affinity or KM (Cohn et al., 2007; Faesen et al.,
2011b). Binding of USP1 by WDR48 was sensitive to deletions
within the WD-repeats, indicating the importance of a presumed
propeller domain (Cohn et al., 2007). Efforts to map complemen-
taryWDR48-interacting regionsofUSP1proposedeitheraportion
of the fingers domain (420–520) (Garcı´a-Santisteban et al., 2012)
or a non-conserved insertion (235–408) that includes Ser313
whose phosphorylation was reported to affect the interaction (Vil-
lamil et al., 2012b). This latter possibility is surprising given that
USP12 and 46 also bind WDR48, but lack this insertion. Recent
studies corroborate that Ser313 is not critical for USP1:WDR48
binding and function (Olazabal-Herrero et al., 2015).
To elucidate these aspects of WDR48:USP interaction
and biology, we report the crystal structures of ternary com-
plexes of WDR48:USP46ubiquitin, a binary complex of
USP46ubiquitin, and free WDR48. Structure-based mutagen-
esis combined with direct binding and functional assays validate
our observed WDR48:USP46 interface. Moreover, mutagenesis
of equivalent residues in the WDR48:USP1 system abrogates
both USP1 binding to WDR48 and deubiquitination of a USP1
substrate in cells, suggesting that this interface, distinct fromprior
USP interactions described,may serve as a prototypical example
of activity-modulating b-propeller:USP family interactions.
RESULTS
WDR48 Contains a b-Propeller and a Novel-Fold
Ancillary Domain
To aid crystallization, we identified a stable C-terminal deletion
of WDR48 that excludes the last 97 amino acids (Figure S1).2044 Structure 23, 2043–2054, November 3, 2015 ª2015 Elsevier LtdThe structure of WDR482–580 reveals a b-propeller domain (resi-
dues 27–360) and a curved ancillary domain (13–24 and 362–
561) of novel fold (Table 1; Figure 1). The relatively canonical
seven-bladed b propeller creates a toroid with a narrow central
pore. Modest insertions are present within blades 3 (12-residue
insertion 146–168) and 7 (26-residue insertion 327–353, of which
337–345 are disordered in our structure) on the outer bottom
surface of the toroid. Many propellers have a circularly closed to-
pology as a first amino-terminal strand contributes to the final
blade (Figure S2). Here, the seventh blade has a full complement
of four strands while the WDR48 amino-terminal residues 13–24
are unexpectedly incorporated as an integral strand within the
ancillary domain rather than the propeller (Figure 1). This results
in proximal positioning of the interdomain tethers that leaves the
top of the propeller relatively exposed, and may enable hinged
motions between the propeller and ancillary domains.
The ancillary domain is offset to one side of the propeller ring,
centered over blades 1 and 2. A 3D similarity search (Dali [Holm
and Sander, 1995]) indicates a novel overall fold while also iden-
tifying a propeller blade as a substructure embedded within the
ancillary domain architecture. This curved blade, formed from an
additional eighth WD-repeat in the WDR48 primary sequence, is
stacked on a second arched, five-stranded b sheet that includes
the N-terminal strand (Figure 1). The outer convex faces of those
curved sheets pack against loops and short a helices out to the
last discernible residue (561), which terminates on the upper face
of the ancillary domain, away from the b propeller.
Binary Complex of USP46Ubiquitin
We determined the 1.9-A˚ resolution structure of a covalently
coupled USP4625–366ubiquitin complex (Table 1). The structure
shows a canonical USP architecture with thumb, palm, and
extended fingers subdomains (Figure 2). Ubiquitin substrate is
cradled between the fingers and the inner palm/thumb regions
with its C-terminal sequence leading into the cysteine protease
active site, where the conjugated ubiquitin G76 is covalently
linked to the catalytic USP46 C44. The tip of the fingers domain
features a zinc ribbon motif with a coordinated zinc ion. The
USP46:ubiquitin interface buries 1,825 A˚2 of surface area on
each protein. Ubiquitin-proximal loops, the ‘‘switching’’ loop
equivalent, and the catalytic center all have unambiguous elec-
tron density showing their contacts with ubiquitin and its C-ter-
minal tail. Similar to many USP homologs, USP46 has an inser-
tion at the junction of the thumb and fingers domains that is
disordered in our model (USP46 residues 143–163); USP1 has
here a larger 195-residue insertion. The preceding helix (aE) pro-
vides a central shaft to the USP46 architecture, and it continues
several turns beyond the main body of the protein as it leads
into this disordered gap. Annotated comparisons between
USP structures are shown in Figure S3.
WDR48 Contacts USP46 via a b-Propeller:USP46
Fingers Interaction
To analyze the interactions of these proteins in a ternary com-
plex, we crystallized and determined the 3.35-A˚ resolution struc-
ture ofWDR482–580 bound to a USP4625–366ubiquitin conjugate
(Table 1). TheWDR48 b-propeller domain (residues 27–360) pro-
vides a platform for interaction at the toroid’s top center to bind
the very distal portion of the USP46 fingers domain on the outerAll rights reserved
Table 1. Data Collection and Refinement Statistics
WDR482–580 USP46Ubiquitin WDR482–580:USP46Ubiquitin WDR48:USP46Ubiquitin
Data Collection
Space group I4122 C2221 I222 C2
Cell dimensions
a, b, c (A˚) 139.5, 139.5, 235.1 90.6, 105.1, 134.7 103.4, 154.2, 182.9 211.3, 103.8, 191.0
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90 90, 119.0, 90
Resolution (A˚) 50–3.0 (3.11–3.0) 50–1.9 (1.967-1.9) 50–3.35 (3.49–3.35) 50–3.88 (4.02–3.88)
Rmerge 0.13 (0.85) 0.067 (0.77) 0.12 (0.72) 0.17 (0.69)
I/sI 19.4 (3.2) 16.3 (2.4) 13.8 (2.8) 5.7 (1.4)
Completeness (%) 99.9 (99.1) 98.9 (97.8) 99.6 (96.1) 93.6 (82.3)
Redundancy 16.1 (16.5) 6.2 (6.0) 7.7 (7.7) 3.5 (3.1)
Wilson B factor 66.9 29.4 88.8 79.2
Phasing FOM 0.259 – – –
Phasing Sites 8 Au – – –
Refinement
Resolution (A˚) 50–3.0 (3.11–3.0) 50–1.9 (1.967–1.9) 50–3.35 (3.49–3.35) 50–3.88 (4.02–3.88)
No. of reflections 380,955 (37,958) 311,236 (29,475) 162,990 (15,378) 110,113 (8,555)
Rwork/Rfree 0.1892/0.2336 0.1887/0.2243 0.1952/0.2701 0.2235/0.2719
No. of atoms 4,316 3,675 7,350 15,556
Protein 4,139 3,185 7,315 15,554
Ligand/ion 17 1 1 2
Water 160 489 34 0
Average B factors 71.0 32.5 57.5 58.7
Protein 71.1 30.6 57.7 58.7
Ligand/ion 125.8 23.3 86.9 86.9
Water 61.1 44.7 30.0 NA
Root-mean-square deviations
Bond lengths (A˚) 0.014 0.004 0.014 0.012
Bond angles () 1.98 0.84 1.96 1.54
Ramachandran (%)
Favored 91.0 97 92 93a
Outliers 0.77 0.52 1.2 0.81a
Clashscore 5.43 3.46 13.96 11.14
aThe full-length WDR48:USP46ubiquitin complex includes only a poly-ala trace of the C-terminal residues (563–671) and was refined using Rama-
chandran restraints.surface of the zinc-coordinating motif (Figure 3). The relatively
small (720 A˚2 buried surface area) but well-packed junction in-
cludes many charged and polar side chains extending from
each partner (Figure 3B). The USP fingers lie between ubiquitin
and the WDR48 b propeller with the coordinated zinc ion of
USP46 poised above the central pore of the propeller. Unexpect-
edly, this ‘‘interface-1’’ leaves the bulk of USP46 quite removed
fromWDR48, as the active-site Cys44 is 41 A˚ from the nearest
WDR48 residue. The USP46-bound ubiquitin is closer, however,
sheltered adjacent to the concave inner face of the WDR48
ancillary domain. Surprisingly, there is a small gap and no
direct contacts between WDR48 and ubiquitin, despite a
seeming shape complementarity of the nearby surfaces (Figures
3C and 3D).
Alignment of our separate structures onto the complex shows
very little conformational change (Figure S4) (Ca root-mean-
square deviation for isolated versus complex-bound species:Structure 23, 2043–20WDR48 = 1.4 A˚, USP46ubiquitin = 1.1 A˚, ubiquitin only =
0.3 A˚.) For WDR48, the only large shift occurs in the extended
loop of blade 3 (residues 149–160, Figure S4) where a symme-
try-related USP46 neighbor packs between this outside region
of the b propeller and the adjoining ancillary domain helix E (res-
idues 537–545). This second interface (‘‘interface-2’’) is medi-
ated by two b strands of USP46 (residues 281–295) that form
hydrogen bonds extending the b sheet of WDR48 blade 2 (Fig-
ure 4). This interface occludes slightly more surface area
(1,112 A˚2) than observed for interface-1, but is somewhat less
compelling in its prevalence of sequence-insensitive backbone
interactions, the outward orientation of ubiquitin relative to the
WDR48, and that it again leaves the USP46 active site relatively
distant (Cys44 is 31 A˚ from the nearest WDR48 residue).
While protein interactions are most common on the top of
b-propeller scaffolds, examples also exist using side, loop,
and bottom surfaces (Xu and Min, 2011). We therefore designed54, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2045
Figure 1. Structure of WDR48
WDR48 is colored blue (N terminus) to red (C terminus). The view is oriented
looking obliquely onto the b-propeller top surface (blades numbered 1–7),
followed by the ancillary domain including an eighth propeller blade sub-
structure (marked 8). Helical features in the ancillary domain are labeled
alphabetically from A to F. Electron density was not interpretable beyond
residue 561, marking the C terminus of the ancillary domain at the upper left of
the figure. See also Figure S2.
Figure 2. USP4625–366Ubiquitin Structure
USP4625–366ubiquitin structure is colored as USP46 thumb (blue), palm
(green), and fingers (gold) domains with bound ubiquitin (orange). The zinc
ribbon cysteines are shown as sticks at the tip of the fingers domain coordi-
nating a zinc ion (gray sphere). Ubiquitin G76 is covalently attached to the
USP46 active site C44 (with catalytic residues H313 and D329 also shown as
sticks). Disordered loops are indicated with dashed lines and residue number
boundaries.
(A) Side view showing the extended fingers domain cradling ubiquitin and the
passage of the C-terminal ubiquitin segment.
(B) Top view highlights the long central helix of the USP thumb domain (aE) that
leads to the disordered linker (142–164) between conserved thumb and fingers
elements at the top of the image.
See also Figure S3.structure-based mutations to provide rigorous experimental
proof as to which interface is functionally relevant for USP
activation.
In interface-1 we created a WDR48 triple mutation of K214E/
W256A/R272D (termed WDR483X) to alter the charge property
and surface shape of WDR48. We additionally mutated WDR48
S170Y, which we anticipated would cause a steric clash with
USP46 in the observed interface-1 interaction (Figure 3B).
USP46 E186 makes several contacts to the K214/W256/R272
patch of WDR48, so we also created a USP46 E186K charge
reversal to test for disrupted binding and function. Interface-
2’s b-sheet interactions with WDR48 had much less reliance
on side chains and thus offered fewer opportunities for obvious
disruptive mutations. We selected L152R/S155W on the
WDR48 blade 3 insertion, as these outward-oriented larger
amino acid substitutions are expected to create a steric clash
with the observed position of USP46 (Figure 4B).
USP46 In Vitro Assays Confirm the Importance of
Interface-1
USP46 and WDR48 variants were tested for interaction via a
direct binding assay. WDR48 L152R/S155W mutations in inter-
face-2 had minimal impact on WDR48:USP46 association (Fig-
ure 5A). By contrast, WDR48 mutation S170Y of interface-1
greatly reduced the observed interaction. An even more striking
effect was observed for WDR483X, which had no detectable
interaction with (WT) USP46, thus confirming the importance2046 Structure 23, 2043–2054, November 3, 2015 ª2015 Elsevier Ltdof interface-1 for binding between these two proteins. In addi-
tion, WDR483X interaction with USP46 was partially restored
by the USP46 E186K charge-reversal mutant. Together these
complementary mutants showed weak but measurable binding
(Kd = 3.6 mM, Figure S5). WT WDR48:USP46 has a surprisingly
tight affinity (0.1 nM with a slow koff) given the small size of the
interface observed in the structure; however, unlike many pro-
tein-protein interfaces, the USP46-WDR48 interface is mainly
composed of charged interactions, not buried hydrophobic
residues. Our kinetic analysis also revealed that the reduced
binding of the S170Y mutant (100 nM) is primarily a result ofAll rights reserved
Figure 3. WDR482–580:USP4625–366Ubiquitin
Complex
WDR48 propeller (dark blue), ancillary domain
(light blue, N-terminal strand in cyan), USP46
(ivory), and ubiquitin (orange) are colored. Spheres
mark the coordinated zinc ion (gray) at the outer
USP46 fingertips and the sulfur atom of the DUB
catalytic site cysteine (gold).
(A) WDR48:USP46 interface-1 with the USP46
fingertips directly over the top center of the b
propeller. The active-site Cys sulfur atom is 41 A˚
from the nearest WDR48 residue.
(B) Closer view of interface showing amino acid
side chains involved in the WDR48:USP46 inter-
action. Residues selected for mutagenesis are
labeled and emphasized in green (WDR48) or
magenta (USP46).
(C and D) Molecular surfaces of WDR48 (b pro-
peller, navy; ancillary domain, slate blue; N-termi-
nal strand, cyan) and ubiquitin (orange) juxtapose
a ribbon representation of USP46 (ivory) in the
ternary complex interface-1 arrangement. (C) Ori-
ented as (A), the USP46 fingers lie between
WDR48 and ubiquitin. The zinc ion (gray sphere) is
positioned over the b-propeller pore. The WDR48
ancillary domain has a gently curved inner wall that
complements ubiquitin’s surface, but a small gap
remains between the two proteins. (D) View is
rolled 90 toward the viewer.
See also Figure S4.a faster koff relative to WT protein, while maintaining similar kon
(see Figure 5C).
The functional impact of the mutations was gauged in vitro us-
ing a ubiquitin-AMC (7-amino-4-ethylcoumarin) substrate in
which cleavage by USP46 liberates the fluorescent dye. Consis-
tent with the binding assay, WDR48 L152R/S155W showed
stimulation of the USP46 reaction rate similar to that of WT
WDR48 (Figure 6). In contrast, at 200-nM concentrations of
USP46 and WDR48, both of the interface-1 mutation combina-
tions tested abrogated WDR48 stimulation such that reaction
rates were indiscernible from our negative control of USP46
alone. At a higher WDR48 concentration (4 mM, 20-fold molar
excess over USP46), the S170Y mutant showed a weak stimula-
tion of USP46 activity, while the WDR483X mutant stimulation re-
mained undetectable, a pattern that correlates exactly with the
binding measurements. In this in vitro setting, a construct con-
sisting of only the WDR48 b propeller (27–359) was able to
stimulate USP46 almost as well as the full-length WT WDR48
construct, again corroborating the importance of interface-1,
which, unlike interface-2, is containedwholly within the b-propel-
ler domain. Finally, similar to the weak rescue of WDR483X bind-
ing, USP46 E186K showed slightly better activity in the presence
ofWDR483X compared with negligible stimulation byWTWDR48
(Figure S6C). All WDR48 reagents were tested alone in this assay
to ensure a lack of any contaminating deubiquitinase activity
(Figure S6A). Mutation of the catalytic cysteine 44 to serine in
USP46 also demonstrated that the unstimulated rates observed
for our designed mutants were in the regime of the catalyticallyStructure 23, 2043–20dead deubiquitinase, and that stimulation was dependent on
USP46 catalytic activity (Figure S6B).
USP1 Cellular Assays
To test whether the functional significance extends to more
distantly related deubiquitinases, we examined binding and deu-
biquitination in USP1-based cellular assays. USP1 has but 17%
identity with USP46 and includes several larger insertions. In light
of the bindingmode indicated by our structures, we designed the
USP1 E444K mutation, homologous to USP46 E186K. We also
created USP1 mutation S313A that was previously implicated
as a phosphosensitive WDR48-interaction point (Villamil et al.,
2012b).
WT and mutant WDR48 and USP1 constructs were trans-
fected in 293T cells and tested in co-immunoprecipitation as-
says. As seen in Figure 7A, WDR48 co-immunoprecipitates
efficiently upon pull-down of FLAG-tagged WT USP1, but has
no visible interaction with the E444K USP1 mutant, corrobo-
rating our in vitro observations with USP46 E186K. In contrast,
in our assay USP1 S313A is as robust as WT USP1 for co-immu-
noprecipitation of WDR48. Mutant WDR48 was also tested in an
HA-tagged format. WT WDR48 (HA tag) efficiently precipitated
with FLAG-tagged USP1 while interaction with the WDR483X
mutant could not be detected (Figure 7B).
USP1 E444K was further assayed for its ability to deubiquiti-
nate the transcription factor ID2. Monoubiquitinated ID2 was
identified as a biological substrate of USP1 in the context of
cellular differentiation in osteosarcoma (Williams et al., 2011).54, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2047
Figure 4. Interface 2 between WDR48 and
USP46 Represented as in Figures 3A and 3B
(A) An extended loop of USP46 is bound between
the side of the WDR48 b propeller and its ancillary
domain.
(B) Close-up showing contributions from the
WDR48 ancillary domain helix at the top of the
figure, the blade 2 b sheet at right, and the blade 3
insertion below that surround the USP46 loop
(residues 281–294). WDR48 residues selected for
mutation (L152, S155) are emphasized as green
sticks.USP1 and WDR48 were transfected with ID2 (FLAG tag) and
ubiquitin (HA tag). Sample loads were normalized for total ID2
(Figure 7C, a-FLAGWB box) allowing appreciation of the varying
levels of ubiquitinated ID2uponUSP1modulation. In theabsence
of transfected USP1, ID2 is present in a ubiquitinated form (Fig-
ure 7C, lane 2) that leads ultimately to its degradation (see
absence of a-FLAG ID2 signal in ‘‘input’’ section in this lane).
Transfection of WT USP1 leads to the expected dramatic reduc-
tion of Ub-ID2 by deubiquitination (lane 3). Upon transfection of
catalytically inactiveUSP1 (C90S, lane5), ubiquitinated ID2 levels
are maintained, similar to the control lacking USP1 transfection
(lane 2). The USP1 E444K mutation (lane 4) has an intermediate
effect, as it does show some reduction of Ub-ID2, though not to
the extent observed for WT protein. Given that transfected pro-
teins including USP1 E444K are highly overexpressed, we inter-
pret even this moderate persistence of the monoubiquitinated
ID2 as a significant abrogation of deubiquitinase function in the
E444K setting. Taken together, our series of experiments points
to this being a result of diminished interactionwith the stimulatory
WDR48 co-factor, and provides evidence that USP1 shares a
similar mode of interactionwithWDR48 as observed in our struc-
ture of the WDR48:USP46ubiquitin ternary complex.
The Full-Length WDR48 Ternary Complex Suggests a
Ubiquitin-Proximal WDR48 C-Terminal SUMO-like
Domain
We crystallized a ternary complex that included full-length
WDR48 bound to the USP4625–366ubiquitin conjugate. While
the 4-A˚ diffraction limit of these crystals was not sufficient for
de novo construction of the missing putative SUMO-like domain
(SLD) of WDR48 (Yang et al., 2011), a clear solvent-protein
boundary and strong statistics validated the WDR482–580:
USP4625–366ubiquitin complex molecular replacement solution
we identified. Furthermore, difference density indicating the
missing domain clearly extended fromour extantWDR48C termi-
nus, encircling the USP46-bound ubiquitin and approaching the
thumbsubdomain ofUSP46over the top of the ubiquitinmolecule
(Figures 8 and S7). We identified 3 a-helical features within this
density that guided positioning of a high-resolution SUMOmodel
(PDB: 2LAS) whose topology traced all the significant observable
features in the lower-resolution maps. Furthermore, while end
points were not considered while positioning SUMO, the final2048 Structure 23, 2043–2054, November 3, 2015 ª2015 Elsevier Ltd All rights reservedpose showed compelling alignment of
the SUMO amino terminus within density
directly adjacent to its prescribed attach-ment point on ourWDR48 structure (Figure S7F).While the limited
side-chain detail precludes any sequence registration, these re-
sults indicate that the C-terminal domain of WDR48 adopts a
modified SUMO-like fold with slightly longer helical insertions.
Built here as a polyalanine trace, the fully elaborated SLD domain
would contact ubiquitin, and is in a compelling orientation relative
to the USP46ubiquitin conjugate (Figure 8).
DISCUSSION
WD-repeat proteins, one of the most populous families in eu-
karyotes, are heavily involved in interactions with USP members
of the DUB family (Cohn et al., 2007; Sowa et al., 2009). We
have elucidated a detailed view of WDR48 in complex with
USP46ubiquitin. A charged surface atop the WDR48 b-propel-
ler platform creates the primary binding interface contacting the
zinc ribbon module on the outer and very distal tip of the USP46
fingers domain. Notably removed from the USP46 active site, the
interface is completely distinct from prior examples in activation
of either USP7 by its UBL domains (Faesen et al., 2011a) or sta-
bilization of the yeast Ubp8 in the deubiquitinase module of the
SAGA complex (Ko¨hler et al., 2010; Samara et al., 2010). In those
cases, the involvement of active-site proximal palm/thumb sur-
faces makes it simpler to envision how stimulatory co-factors
could influence specific active-site arrangement and thereby
affect enzymatic turnover (kcat) more than substrate binding
per se (KM). Such a kcat-oriented activation mechanism has
also been ascribed to WDR48’s effects on USP proteins (Cohn
et al., 2007; Faesen et al., 2011b; Villamil et al., 2012a). Given
the distinct binding mode elucidated here, it is less straightfor-
ward to reconcile this structure with direct active-site modula-
tion, yet we propose a mechanism centered on WDR48-depen-
dent USP stabilization that is consistent with implications from
our observations and kcat modulation.
The WDR48 propeller alone is sufficient to activate USP46
almost as well as full-length WDR48 (Figure 6). The high-resolu-
tion USP46ubiquitin structure derives from crystals that grew in
the presence of the WDR482–336 propeller domain. Similarly,
despite the chemically reactive warhead on modified ubiquitin,
successful generation of the USP46ubiquitin adduct required
WDR48 (see Experimental Procedures). While inconclusive of
the absolute state of USP46 in solution, we were able to obtain
Figure 5. Direct Binding of WDR48 Variants to Singly Biotinylated USP46 as Measured by Biolayer Interferometry
(A) Raw sensorgrams show the association of WDR48 variants to immobilized USP46 (plotted as nm response as a function of time) for a similar range of analyte
concentrations (WT andWDR483X, 0–25 nM; L152R/S155W and S170Y, 0–20 nM). Zero-analyte sensorgrams are denoted by open circles. Inset shows zoom of
S170Y sensorgrams.
(B) Raw sensorgrams for a broader range of S170Y analyte concentration (0–313 nM) confirms binding above background.
(C) Zero-analyte controls were subtracted from sensorgrams in (A) and (B) and the resulting data fit to determine kon, koff, andKD for each variant (see Experimental
Procedures and Figure S5).crystals of apo USP46, but poor diffraction led only to a partial
molecular replacement solution in which the bulk of the fingers
domain was not apparent in the electron density (data not
shown). Taken together, these observations suggest a mode of
activation whereby WDR48 stabilizes the otherwise labile
USP46 through direct interaction with the distal region of the
USP46 fingers with possible indirect allosteric effects on theFigure 6. Activation of USP46 Catalytic Activity by WDR48 Variants
(A) Addition of 200 nMWT (black circles), b-propeller domain (black squares), or L
Ub-AMC substrate, whereas WDR48 mutations within interface 1 (S170Y, blue ci
alone control.
(B) Similar results were obtained at 20-fold molar excess of WDR48 variants over
plotted as a function of Ub-AMC concentration, where error bars represent stan
(C) While the data in (A) and (B) do not support explicit determination of kcat and K
the data.
See also Figure S6.
Structure 23, 2043–20active-site configuration. In isolation, USP1, USP12, and
USP46 are relatively inefficient enzymes with slow turnover (Fae-
sen et al., 2011b), whichmay be tied to transient, non-productive
interactions between enzyme and substrate. Stabilization of a
malleable apo USP46 to favor an active conformation would shift
the equilibrium of association and promote productive interac-
tion between ubiquitin and USP46. While we anticipate a similar152R/S155W (gray circles) WDR48 variant activates 200 nM USP46 to cleave a
rcles; WDR483X, red circles) show minimal activity comparable with the USP46
USP46 (4 mM). For (A) and (B) the average rate of Ub-AMC cleavage (mmol/s) is
dard deviations (n = 3).
M values, the ratio of kcat/KM was determined from the slopes of the linear fits of
54, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 2049
Figure 7. Co-immunoprecipitation of USP1
and WDR48 and Cellular Deubiquitination
of ID2 by USP1
(A) WDR48 co-immunoprecipitates with both WT
and S313A FLAG-tagged USP1, while the E444K
USP1 mutant abrogates such interaction.
(B) WTWDR48 co-immunoprecipitates with FLAG-
tagged USP1 (lane 3), while the WDR48 triple
mutant (3X) does not (lane 4).
(C) Transfection of ID2-FLAG, HA-ubiquitin,
and WDR48 leads to observation of a mono-
ubiquitinated ID2 band (lane 2, upper panel), which
is targeted for degradation (minimal intensity of
a-FLAG ‘‘input’’). Lanes were normalized for total
ID2 (see a-FLAGWB in first subpanel). Inclusion of
transfected WT USP1 results in ID2 deubiquitina-
tion (lane 3). Transfection of USP1 E444K shows
diminished deubiquitination (lane 4), though not to
the extent of the catalytically impaired USP1 C90S
(lane 5).mode of interaction for some WD-repeat proteins, the USP12
and USP46 co-factor WDR20 has low sequence homology to
WDR48, and purification of a WDR20:WDR48:USP ternary com-
plex (Kee et al., 2010) indicates that distinct propeller:USP inter-
action modes are likely to be found as well.
Beyond the propeller domain, we suggest that the C-terminal
region ofWDR48 is poised for roles in coordination of cellular co-
factors and ubiquitin. The architecture of full-length WDR48
further elaborates this notion. The post-propeller WDR48 ancil-
lary domain displays a concave ubiquitin-encompassing arch
whose interior surface is more reminiscent of a chaperone-like
environment designed to sterically shield the ubiquitin without
specific interaction. Our experimental density for the intact
WDR48 ternary complex, however, does indicate a small region
of contact between the WDR48 C-terminal SLD domain and
ubiquitin. It will be important to explore the nature of this contri-
bution, whether as a ubiquitin-sensing domain, a surrogate cap
replacing a cleaved polyubiquitin extension, or a simple C-clamp
shape providing further stabilization compared with the ‘‘open-
faced’’ binding of the propeller alone, or, more speculatively,
whether this small WDR48 contact may abet turnover in clearing2050 Structure 23, 2043–2054, November 3, 2015 ª2015 Elsevier Ltd All rights reservedspent ubiquitin from the USP pocket. We
are interested in whether the dynamics
of WDR48 influences such processes
such that tightening of the ancillary
domain around ubiquitin may shift the
SLD even closer than its current 9-A˚
approach to the USP46 thumb domain
and its active-site proximal loops.
The WDR48 SLD has also been impli-
cated in recruitment of USP1 substrate
complexes. SUMO-like interacting motifs
(SLIM) were identified in FANCI and
hELG, respective partners of USP1
substrates FANCD2 and PCNA (Yang
et al., 2011). Our structure positions the
WDR48SLD inaplausible orientation rela-
tive to the expected position of substrateprotein opposite the cradled ubiquitin and WDR48 propeller
(Figure 8D). Alignment of a SUMO-interacting motif (SIM) (PDB:
2LAS) onto the WDR48 SLD indicates the expected position of
a substrate partner’s SLIM peptide (Figure 8C). In the context
of such multiprotein complexes, this recruitment and orientation
of substrate may contribute to more efficient catalysis in addition
to the stimulation provided by the b-propeller interaction.
We provide experimental evidence that the WDR48:USP46
binding mode is conserved across the WDR48-dependent class
of USPs. Our structure-based mutations validated the impor-
tance of the propeller interface-1, and showed an excellent
correlation between diminished binding of WDR48 and impair-
ment of USP deubiquitinase activity. Selected mutations in
this WDR48 surface (i.e. K214E/W256A/R272D) that affected
USP46 binding and function were also detrimental to USP1.
Likewise, mutation of USP1 E444K, analogous to the impactful
USP46 E186Kmutation, abrogatedWDR48 binding and stimula-
tion of USP1 deubiquitinase activity. Homology models of USP1
and USP12 show conserved alignment of several features on the
outer tip of the USP fingers domain where WDR48 interaction
is observed, while non-WDR48-dependent USPs have poor
Figure 8. Data and Schematic for a Full-
Length WDR48:USP46:Ubiquitin Ternary
Complex
(A) 3.9 A˚ electron density of an Fo-Fc difference
map contoured at 3s (magenta) and 1.5s (gray)
delineates the WDR48 C-terminal domain absent
from the search model.
(B) The refined polyalanine build shows a modified
SUMO-like domain (SLD) ofWDR48 in cyan further
encircling the USP46-bound ubiquitin.
(C) Alignment of a SUMO structure (PDB: 2LAS)
onto the WDR48 SLD indicates the position of a
SUMO-interacting motif (SIM) peptide (bright
green, CPK), and thereby the expected location of
analogous WDR48 SUMO-like interacting motifs
(SLIM) as identified in some USP1 substrate
complexes. The molecular surfaces shown for
WDR48 and USP46 highlight the relatively en-
closed space of the bound ubiquitin (orange).
(D) The schematic suggests relative positions of
substrate complexes, wherein an SLIM-bearing
partner of the ubiquitinated substrate is recruited
by the WDR48 SLD, while the ubiquitinated sub-
strate protein itself is expected to bind in the
proximal ubiquitin location on the outer surface of
the USP palm/thumb domains.
See also Figure S7.conservation of this pattern (Figure S8). The unique binding
mode elucidated here thus provides a framework to guide further
exploration into the role of the larger USP1 insertions and the
particular interactions of USP12 and USP46 in mediating their
respective biological functions in cancer and signaling. The un-
expected position of the WD protein relative to USP and its
bound ubiquitin broadens the scope of potential allosteric mech-
anisms, provides a platform for elucidating therapeutic interven-
tions aimed at the WDR48:USP1 interface, and invigorates our
interrogation of the inter-connectedness of components of the
USP architecture.
EXPERIMENTAL PROCEDURES
Protein Purification
WT or mutant N-terminal His-tagged WDR48 (1–677, 2–580, or 2–336) and
USP46 (25–366) were expressed in baculovirus-infected Trichoplusia ni cells,
harvested by centrifugation, and stored at 80C. Cells were lysed in 25 mM
Tris (pH 8.0), 150 mMNaCl, 5 mM b-mercaptoethanol (bME), and 5% glycerol.
Clarified lysate (40,000 rpm, 1 hr) was loaded on an Ni-nitrilotriacetic acid af-
finity column (Qiagen) washed with buffer A (50 mM Tris [pH 8.0], 150 mM
NaCl) plus 5 mM bME and 10 mM imidazole, and eluted with buffer A plus
300 mM imidazole. Tobacco etch virus-digested protein (buffer A plus 1 mM
tris(2-carboxyethyl)phosphine (TCEP), 4C overnight) was diluted and loaded
on a QHP column (GE Healthcare) and eluted by a NaCl gradient in 25 mM
Tris (pH 8.0) and 1 mM TCEP. The protein was purified on a HiLoad 16/60
Superdex 200 size-exclusion chromatography (SEC) column (GE Healthcare)
equilibrated in buffer B (25 mM Tris [pH 8.0], 100 mM NaCl, 1 mM TCEP).
Peak fractions were pooled and concentrated to 10 mg/ml.Structure 23, 2043–2054, November 3, 2015 ªUbiquitin and ubiquitin 2-bromoethylamine
(Ub-BEA) were prepared as described previously
(Huang et al., 2012). Reaction of USP46 with
Ub-BEA was inefficient without WDR48 present.
Therefore, WDR48 was mixed with excess
USP46 (25–366) and the complex purified by
SEC (HiLoad 16/60 Superdex S200; GE Health-care) in buffer B. Freshly prepared Ub-BEA was incubated with the concen-
trated WDR48:USP46 complex for 1–6 hr at room temperature, and again
purified by SEC as above to remove excess Ub-BEA. The ternary complex
was concentrated to 20 mg/ml, flash-frozen in liquid nitrogen, and stored
at 80C.
Crystallization
All crystals were grown by hanging-drop vapor diffusion experiments at 19C
using equal ratios of protein and well solutions. All samples were cryopro-
tected by brief washes in well solution augmented with listed cryoprotectants
prior to flash-freezing in liquid nitrogen for data collection.
WDR482–580 crystals were grown by streak-seeding drops set with 0.72 M
sodium phosphate, 0.72 M potassium phosphate, 90 mM HEPES (pH 7.5)
well solution. Gold derivatives were prepared by soaking individual crystals
for 20 min in 0.5 mM Au(I) potassium cyanide (Hampton Research HR2-444-
01), 5% glycerol, 0.72 M sodium phosphate, 0.72 M potassium phosphate,
and 90 mM HEPES (pH 7.5). Cryoprotectant solution included 20% glycerol.
20 mg/ml USP4625–366 with bound Ub-BEA crystallized from a sample
including WDR482–336 set against a well solution of 3.6 M sodium formate.
Cryoprotectant solution included 25% glycerol.
15 mg/ml WDR482–580:USP4625–366:Ub-BEA ternary complex was crystal-
lized in 0.1 M Tris (pH 8.8), 0.1 M NaCl, 5% EtOH, and 15% 2-methyl-2,4-
pentanediol (MPD) by streak seeding using crushed initial hit crystals.
Cryoprotection was achieved with well solutions augmented to 30% MPD. A
similar protocol was successful for crystallization of a full-length WDR481–677:
USP4625–366:Ub-BEA ternary complex using well solution of 15% MPD, 0.1 M
NaCl, 0.1 M HEPES (pH 7.0).
Data Collection and Refinement
Data were collected at Stanford Synchrotron Radiation Lightsource beamline
7-1 (WDR48, 1.02638 A˚ wavelength) and the Advanced Light Source beamline2015 Elsevier Ltd All rights reserved 2051
5.0.2 (USP46:Ub, 0.9794 A˚ wavelength; WDR48:USP46:Ub, 1.000 A˚ wave-
length). The novel WDR48 structure was built with phases determined by sin-
gle-wavelength anomalous diffraction using derivatized gold atoms. Eight gold
locations were identified using PHENIX AutoSol (Terwilliger et al., 2009), which
allowed construction of the apo protein model that was refined to R/Rfree of
18.9/23.4 with 0.8% Ramachandran outliers. The ternary complex structure
was determined by molecular replacement using the apo WDR48 structure
and a USP7:ubiquitin complex (1NBF) as search model, refined to R/Rfree of
19.5/27.0 with 1.2% Ramachandran outliers. The USP46:ubiquitin structure
was determined by molecular replacement using initial search models of the
USP46 extracted from the ternary complex and ubiquitin extracted from
PDB: 3TMP, and refined to R/Rfree of 18.9/22.4 with 0.5% Ramachandran
outliers. The full-length WDR48:USP46ubiquitin ternary complex was deter-
mined bymolecular replacement using the truncatedWDR48 ternary complex.
Helical features in additional density were used to orient a SUMO structure
(PDB: 2LAS) to guide manual construction of a poly-ala trace. At this low res-
olution, refinement in PHENIX included Ramachandran restraints and use of
the higher-resolution structures as reference targets to avoid degradation of
geometric terms (R/Rfree 22.4/27.2, 0.8% Ramachandran outliers). The poly-
ala trace is meant to serve as a coarse indicator of the position and topology
of the SLD domain, but does not permit detailed atomic analysis. All models
were constructed using iterative rounds of manual building in Coot (Emsley
and Cowtan, 2004), and refinement in PHENIX (Adams et al., 2010) and Buster
(Bricogne et al., 2011) (Table 1).
In Vitro Binding
To assess the binding of WDR48 constructs to USP46, we used biolayer inter-
ferometry as implemented in the OctetRed system (ForteBio). Streptavidin tips
(ForteBio) were equilibrated in binding buffer (PBS plus 1 mM TCEP or DTT,
0.02% Tween 20, 0.1 mg/ml human serum albumin or BSA), then introduced
into 5 mg/ml biotinylated USP46 (200 ml) and loaded to a loading density of
approximately 3 nm (well below saturation). Tips were then equilibrated in
binding buffer and introduced into wells containing a serial dilution of a
WDR48 variant (200 ml). Association was monitored for 5–180 min (depending
on the binding kinetics of the variant), then tips were moved to wells containing
only binding buffer (200 ml) to monitor dissociation. Zero-analyte controls were
performed to correct for drift over the course of each experiment, and these
sensorgrams were used to produce background-subtracted curve sets.
Where binding was measurable, it was typically with very slow on- and off-
rates such that equilibrium conditions were difficult to achieve. For such non-
equilibrium sensorgrams (e.g. WT and L152R/S155W), both the association
and dissociation phases were fitted with a 1:1 simple pseudo-first-order inter-
action model (i.e. d[Analyte-Ligand]/dt = kon.[Analyte].[Ligand]  koff.[Analyte-
Ligand]), where [Analyte-Ligand] is complex formed. Variables kon and koff
were constrained to globally fit values over the curve set. The Rmax was
allowed local values for each curve, as the density of immobilized ligand varies
slightly with each curve owing to the use of separate measuring probes for
each measured curve. For the S170Y mutant, the dissociation phase was
too rapid to accurately measure; however, this weaker binding mutant did
achieve equilibrium conditions. As such, we applied a steady-state model
(Req = (Rmax.[Analyte])/([Analyte] +KD), where Req is the response at equilib-
rium, Rmax is the response at saturation, and [Analyte] is the concentration of
analyte, which is fixed with respect to time) to the steady-state region (time
>200 s) of the curves. Both Rmax and KD were constrained to single global
values. Kinetic constants for S170Y were also determined by fitting the asso-
ciation phases to a first-order integrated rate equation to determine kobs at
various S170Y concentrations. We then used the linear relationship between
kobs and S170Y concentration to determine kon and koff, and thus KD. A similar
kinetic analysis was employed to quantify the weak interaction between
USP46 E186K and WDR483X.
In Vitro Deubiquitination Activity
To assess the deubiquitinating activity of the USP46:WDR48 complex, we
used a ubiquitin-AMC cleavage assay. Complexes of USP46 and WDR48
were formed by incubating the proteins at 400 nM USP46 and either 400 nM
or 8,000 nMWDR48 overnight at 4C. Complexes were thenmixed 1:1with se-
rial dilutions of Ub-AMC (Boston Biochem). The total reaction volumewas 14 ml
per well in a 384-well plate (ProxiPlate-384 F Plus; PerkinElmer), and assays2052 Structure 23, 2043–2054, November 3, 2015 ª2015 Elsevier Ltdwere carried out in PBS with 1 mM TCEP, 0.02% Tween 20, and 0.1 mg/ml
human serum albumin. We monitored the release of AMC using an excitation
wavelength of 345 nm andmonitoring emission at 445 nmwith a 435-nm cutoff
filter. Readings were taken for 1 hr using a SpectraMax M5e plate reader (Mo-
lecular Devices). We determined the slope of the linear regions (from 2,000 to
3,600 s) using linear regression in Kaleidagraph, and converted fluorescence
signal to mmol AMC using an AMC standard curve. Rates (in mmol/s) were
plotted as a function of Ub-AMC concentration. Due to the weak activity of
USP46 we were not able to achieve saturation, and therefore unable to report
rigorous values for KM and kcat. Data were fit to a line to determine kcat/KM.
Cellular Deubiquitination Assays
293T cells were transfected for 48 hr with HA-ubiquitin, FLAG-ID2, and
untagged USP1 (WT, E444K, or C90S) using FuGENE HD (Promega). Cells
were treated with 10 mM MG-132 for 60 min prior to lysis in NP40 lysis buffer
(1% NP-40, 120 mM NaCl, 50 mM Tris-HCl [pH 7.5], 1 mM EDTA) containing
10 mMMG-132, 10 mM N-ethylmaleimide, protease inhibitor cocktail (Roche),
and phosphatase inhibitor cocktail (Roche). Soluble lysates were denatured
with 1% SDS at 95C for 5 min and then diluted 20-fold in lysis buffer.
FLAG-ID2 was immunoprecipitated using anti-M2 FLAG agarose (Sigma-
Aldrich) for 4 hr. Beads were washed in lysis buffer and bound proteins eluted
with LDS sample buffer.
Co-immunoprecipitation
293T cells were transfected with FLAG-USP1 and HA-WDR48 using FuGENE
HD (Promega) for 48 hr and lysed in Triton lysis buffer (1% Triton, 20 mM Tris-
HCl [pH 7.5], 135 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol) con-
taining protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail
(Roche). Soluble lysate was incubated with anti-M2 FLAG agarose (Sigma-
Aldrich) for 4 hr. Beads were washed in lysis buffer and bound proteins eluted
with LDS sample buffer.
Antibodies
Anti-FLAG (Sigma), anti-USP1 (clone 5 3 1010; in-house GNE antibody), anti-
HA (Cell Signaling), anti-WDR48 (clone 9F10; in-house GNE antibody), actin
(clone C4; MP Biomedicals).
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